Infinity Pharmaceuticals Inc (OTCPK:INFIQ)
$ 0.000001 0 (0%) Market Cap: - Enterprise Value: -17.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Infinity Pharmaceuticals Inc at 2020 San Antonio Breast Cancer Symposium - Conference Call Transcript

Dec 09, 2020 / 03:00PM GMT
Release Date Price: $2.24 (-19.13%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Infinity Pharmaceuticals 2020 San Antonio Breast Cancer Symposium. (Operator Instructions) I would now like to introduce host of today's conference call, Ms. Jayne Kauffman. You may begin.

Jayne Kauffman
Infinity Pharmaceuticals, Inc. - Senior Executive Coordinator

Good morning, everyone, and welcome to today's call where we will review TNBC data from MARIO-3, which was presented today during the San Antonio Breast Cancer Symposium, or SABC.

Participants on today's call are Adelene Perkins, Chief Executive Officer; and Dr. Brian Schwartz, Consulting Chief Physician from Infinity Pharmaceuticals; and Dr. Erika Hamilton, Director of the Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute at Tennessee Oncology; and MARIO-3 Lead Study Investigator.

During this call, we may make forward-looking statements about our future expectations and plans including clinical development objectives, the therapeutic potential of our product candidates, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot